Clinical Trial Update: Intravesical Injection of Botox for Treating Therapy Refractory Overactive Bladder in Females

View source ↗

Summary

A completed clinical trial evaluated intravesical injections of Botox for therapy-refractory overactive bladder in women.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Overactive Bladder

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: University of Zurich | Conditions: Overactive Bladder Syndrome | Status: COMPLETED